ExitThursday, September 3, 2026
KKR to sell minority stake in Nordic Bioscience to founder
KKR is selling a minority stake in Nordic Bioscience, a drug development and clinical diagnostics services company, to its founder.
KKR backed the business and helped it double its revenue while expanding its capabilities across R&D services, clinical diagnostics and drug development.
Deal facts
- Target
- Nordic Bioscience
- Business
- Contract research and drug development services company with R&D services, clinical diagnostics and drug development capabilities
- Buyer
- Nordic Bioscience founder
- Seller
- KKR
- Deal type
- Exit
- Status
- Announced, not yet closed
- Announced
- Thursday, September 3, 2026
Sources
- PEI Private EquitySep 3, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.